Not yet recruitingPhase 2NCT06563934

Gut Microbiota in Liver Cancer (Treated With TKIs In Combination With ICIs)

Studying Cap myopathy

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Xu Yong, MD
Principal Investigator
Yong Xu, Dr
Secretary of the Party Committee of the Shenzhen Third People's Hospital
Intervention
Oral enterobacterium capsules(biological)
Enrollment
70 enrolled
Eligibility
18-75 years · All sexes
Timeline
2024 – 2026

Collaborators

Nanjing Xiershou Biotechnology Co., Ltd

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06563934 on ClinicalTrials.gov

Other trials for Cap myopathy

Additional recruiting or active studies for the same condition.

See all trials for Cap myopathy →

← Back to all trials